Sharma Kanika, Ojha Tarun, Dabaria Rajendra, Chhabra Biban, Trivedi Bhargavi Bhaskar, Bansal Monika
Department of ENT, Mahatma Gandhi Medical College & Hospital, Jaipur, Rajasthan India.
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):4405-4408. doi: 10.1007/s12070-021-03070-1. Epub 2022 Jan 7.
The aim of this study is to establish a relationship between vitamin D levels and benign paroxysmal positional vertigo (BPPV) and its recurrence; and to evaluate the remedial effect of vitamin D on BPPV. In a pilot study, 40 patients with clinically diagnosed posterior canal BPPV were evaluated, treated and were followed up for a period of 6 months at ENT Department of Mahatma Gandhi Medical College, Jaipur. All the patients with clinical diagnosis of posterior canal BPPV were tested for 25(OH)D levels at their 1st visit. Patients were divided in two groups after appropriate matching. Group A was given vitamin D supplementation along with canal repositioning manoeuvre (CRM) and group B were only treated by canal repositioning manoeuvre. Patients underwent neuro-otological assessment during follow up visits and recurrent attacks were recorded. This study was conducted on 40 patients with BPPV (26 females and 14 males). The average age was 50 years. Average serum of 25(OH)D at the first visit was (12.2 ng/ml) for group A, and (12.4 ng/ml) for group B, all patients had low serum level of 25(OH)D (below 20 ng/ml). Recurrent BPPV episodes, were significantly lower in group A than that of group B. We second the hypothesis that the patients with BPPV who have insufficient levels of Vitamin D may benefit from vitamin D supplementation and we suggest further epidemiological and pharmacological studies to detect the effect of vitamin D deficiency on development and recurrence of vertigo.
本研究的目的是建立维生素D水平与良性阵发性位置性眩晕(BPPV)及其复发之间的关系;并评估维生素D对BPPV的治疗效果。在一项初步研究中,对40例临床诊断为后半规管BPPV的患者在斋浦尔的圣雄甘地医学院耳鼻喉科进行了评估、治疗并随访6个月。所有临床诊断为后半规管BPPV的患者在首次就诊时均检测了25(OH)D水平。经过适当匹配后将患者分为两组。A组在进行半规管复位手法(CRM)的同时给予维生素D补充剂,B组仅接受半规管复位手法治疗。患者在随访期间接受了神经耳科学评估,并记录了复发发作情况。本研究对40例BPPV患者(26例女性和14例男性)进行。平均年龄为50岁。A组首次就诊时25(OH)D的平均血清水平为(12.2 ng/ml),B组为(12.4 ng/ml),所有患者的25(OH)D血清水平均较低(低于20 ng/ml)。A组BPPV复发发作明显低于B组。我们支持以下假设,即维生素D水平不足的BPPV患者可能从维生素D补充剂中获益,并且我们建议进一步开展流行病学和药理学研究,以检测维生素D缺乏对眩晕发生和复发的影响。